For the quarter ended December 2024, Encompass Health (EHC – Free Report) reported revenue of $1.41 billion, up 12.7% over the same period last year. EPS came in at $1.17, compared to $0.95 in the year-ago quarter.
The reported revenue represents a surprise of +2.05% over the Zacks Consensus Estimate of $1.38 billion. With the consensus EPS estimate being $1.02, the EPS surprise was +14.71%.
While investors closely watch year-over-year changes in headline numbers — revenue and earnings — and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company’s underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock’s price performance more accurately.
Here is how Encompass Health performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net patient revenue per discharge: $21,399 versus the two-analyst average estimate of $21,059.38.
- Total Discharges: 63,839 versus 63,313 estimated by two analysts on average.
- Revenues- Inpatient Rehabilitation: $1.37 billion versus the two-analyst average estimate of $1.33 billion. The reported number represents a year-over-year change of +12.3%.
- Revenues- Outpatient and other: $38.90 million versus $37.68 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +29.7% change.
View all Key Company Metrics for Encompass Health here>>>
Shares of Encompass Health have returned +10.1% over the past month versus the Zacks S&P 500 composite’s +2.1% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Financial Market Newsflash
No financial news published today. Check back later.
